Low incidence of diabetic ketoacidosis with canagliflozin
(HealthDay)—For canagliflozin-treated patients with type 2 diabetes, the incidence of serious adverse events of diabetic ketoacidosis (DKA) is low, according to research published online July 22 in Diabetes Care.
Jul 29, 2015
0
8